Thymidine Kinase Gene Modified Bone Marrow Mesenchymal Stem Cells as Vehicles for Antitumor Therapy

Human Gene Therapy - United States
doi 10.1089/hum.2010.116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells as Cellular Delivery Vehicles for Prodrug Gene Therapy of Glioblastoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

Bone-Marrow-Derived Mesenchymal Stem Cells for Organ Repair

Stem Cells International
Cell BiologyMolecular Biology
2013English

Gene-Modified Bone Marrow Cell Therapy for Prostate Cancer

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2008English

Interferon-Β Gene-Modified Human Bone Marrow Mesenchymal Stem Cells Attenuate Hepatocellular Carcinoma Through Inhibiting AKT/FOXO3a Pathway

British Journal of Cancer
Cancer ResearchOncology
2013English

Enhancement of Immunoregulatory Function of Modified Bone Marrow Mesenchymal Stem Cells by Targeting SOCS1

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Research Progress of Genetic Modified Bone Marrow Mesenchymal Stem Cell Transplantation for the Therapy of Parkinson’s Disease

Advances in Clinical Medicine
2015English

Immunosuppressive Properties of Cloned Bone Marrow Mesenchymal Stem Cells

Cell Research
Cell BiologyMolecular Biology
2007English

Gene Expression During Induced Differentiation of Sheep Bone Marrow Mesenchymal Stem Cells Into Osteoblasts

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Enhanced Proliferation and Differentiation of HO-1 Gene-Modified Bone Marrow-Derived Mesenchymal Stem Cells in the Acute Injured Kidney

International Journal of Molecular Medicine
MedicineGenetics
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy